Company profile
Avista Therapeutics
Developing innovative gene therapies for retinal diseases that have a profound impact on patients' quality of life.
- Industry
- Biotechnology Research
- Employees
- 17
- Headquarters
- Pittsburgh, PA
- Founded
- 2021
- LinkedIn followers
- 3,169
- Office locations
- 1
Avista Therapeutics company summary
Avista Therapeutics is a company in the Biotechnology Research industry, headquartered in Pittsburgh, PA, founded in 2021. On LinkedIn the company has around 17 employees and 3,169 followers.
What technology does Avista Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Avista Therapeutics
Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life. We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and efficient expression, using a minimally invasive intravitreal approach. Our quantitative, in vivo-based approach and clinical ophthalmology expertise allow us to rapidly translate new gene therapies to the clinic. Avista is a UPMC Enterprises portfolio company founded based on the research of Drs. Leah Byrne, Jose Sahel, and Paul Sieving.
Where is Avista Therapeutics located?
Avista Therapeutics lists 1 location.
Compare companies similar to Avista Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Avista Therapeutics avistatx.com | Biotechnology Research | 17 | 2021 | Pittsburgh, PA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Avista Therapeutics
What does Avista Therapeutics do?
Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life. We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and efficient expression, using a minimally invasive intravitreal approach. Our quantitative, in vivo-based approach and clinical ophthalmology expertise allow us to rapidly translate new gene therapies to the clinic. Avista is a UPMC Enterprises portfolio company founded based on the research of Drs. Leah Byrne, Jose Sahel, and Paul Sieving.
How many employees does Avista Therapeutics have?
Avista Therapeutics has around 17 employees on LinkedIn.
Where is Avista Therapeutics headquartered?
Avista Therapeutics is headquartered in Pittsburgh, PA.
When was Avista Therapeutics founded?
Avista Therapeutics was founded in 2021.
Build a lead list from companies like Avista Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.